This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
DSM-Firmenich Croissance future
Future contrôle des critères 4/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for DSM-Firmenich.
Informations clés
n/a
Taux de croissance des bénéfices
n/a
Taux de croissance du BPA
Chemicals croissance des bénéfices | 0% |
Taux de croissance des recettes | n/a |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | None |
Dernière mise à jour | 31 May 2023 |
Mises à jour récentes de la croissance future
Recent updates
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2022 | 8,390 | 454 | 314 | 965 | N/A |
9/30/2022 | 9,582 | 837 | 412 | 1,056 | N/A |
6/30/2022 | 9,802 | 1,082 | 510 | 1,147 | N/A |
3/31/2022 | 9,503 | 1,081 | 680 | 1,287 | N/A |
12/31/2021 | 7,269 | 820 | 850 | 1,427 | N/A |
9/30/2021 | 7,955 | 660 | 884 | 1,507 | N/A |
6/30/2021 | 7,558 | 493 | 906 | 1,489 | N/A |
3/31/2021 | 7,572 | 423 | 906 | 1,497 | N/A |
12/31/2020 | 8,106 | 448 | 868 | 1,494 | N/A |
9/30/2020 | 7,960 | 510 | 809 | 1,434 | N/A |
6/30/2020 | 8,034 | 557 | 810 | 1,462 | N/A |
3/31/2020 | 9,011 | 722 | 826 | 1,471 | N/A |
12/31/2019 | 7,998 | 675 | 744 | 1,385 | N/A |
9/30/2019 | 8,272 | 820 | 766 | 1,399 | N/A |
6/30/2019 | 8,502 | 794 | 747 | 1,395 | N/A |
3/31/2019 | 9,124 | 934 | 612 | 1,282 | N/A |
12/31/2018 | 9,267 | 1,069 | 698 | 1,391 | N/A |
9/30/2018 | 9,235 | 984 | 657 | 1,310 | N/A |
6/30/2018 | 9,106 | 2,082 | 550 | 1,170 | N/A |
3/31/2018 | 8,908 | 1,942 | 512 | 1,110 | N/A |
12/31/2017 | 8,632 | 1,761 | 441 | 996 | N/A |
9/30/2017 | 8,471 | 1,676 | 431 | 993 | N/A |
6/30/2017 | 8,333 | 738 | 470 | 1,028 | N/A |
3/31/2017 | 8,166 | 711 | 554 | 1,077 | N/A |
12/31/2016 | 7,920 | 645 | 523 | 1,018 | N/A |
9/30/2016 | 7,831 | 588 | N/A | 958 | N/A |
6/30/2016 | 7,778 | 274 | N/A | 914 | N/A |
3/31/2016 | 7,749 | 214 | N/A | 811 | N/A |
12/31/2015 | 7,722 | 174 | N/A | 696 | N/A |
9/30/2015 | 7,607 | 66 | N/A | 800 | N/A |
6/30/2015 | 7,456 | 114 | N/A | 820 | N/A |
3/31/2015 | 7,245 | 115 | N/A | 867 | N/A |
12/31/2014 | 7,051 | 123 | N/A | 808 | N/A |
9/30/2014 | 7,415 | 112 | N/A | 866 | N/A |
6/30/2014 | 7,834 | 138 | N/A | 885 | N/A |
3/31/2014 | 8,362 | 182 | N/A | 1,010 | N/A |
12/31/2013 | 8,858 | 252 | N/A | 998 | N/A |
9/30/2013 | 8,409 | 363 | N/A | 705 | N/A |
6/30/2013 | 8,500 | 335 | N/A | 638 | N/A |
3/31/2013 | 8,486 | 257 | N/A | 584 | N/A |
12/31/2012 | 8,588 | 280 | N/A | 730 | N/A |
9/30/2012 | 9,089 | 453 | N/A | 950 | N/A |
6/30/2012 | 9,107 | 543 | N/A | 1,020 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: 0NPP's forecast earnings growth (20.5% per year) is above the savings rate (1.2%).
Bénéfices vs marché: 0NPP's earnings (20.5% per year) are forecast to grow faster than the UK market (8.9% per year).
Croissance élevée des bénéfices: 0NPP's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: 0NPP's revenue (11.1% per year) is forecast to grow faster than the UK market (5.2% per year).
Croissance élevée des revenus: 0NPP's revenue (11.1% per year) is forecast to grow slower than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if 0NPP's Return on Equity is forecast to be high in 3 years time